Skip to main content
Physician-scientists at IU School of Medicine conduct ground-breaking research to understand polycystic ovary syndrome (PCOS) and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) is a hormonal disorder common among women of reproductive age. Women with PCOS may have infrequent or prolonged menstrual periods or excess male hormone (androgen) levels.

Investigator

4674-Samala, Niharika

Niharika Samala, M.D.

Assistant Professor of Medicine

Read Bio

Open Research Studies for Polycystic Ovary Syndrome

PCOS Cross-Sectional Study

Enrolling: Yes

Principle Investigator: Niharika Samala, MD

Duration: 1 visit

Patient Population: Women ages 18-45 with diagnosis of PCOS, no known diagnosis of nonalcoholic fatty liver disease (NAFLD).

Interested in this study? Please contact the clinical liver research team: iuliverr@iu.edu

Zydus - PCOS

Enrolling: Yes

Principle Investigator: Niharika Samala, MD

Duration: 28 day screening, 24 week treatment.

Patient Population: Women ages 18-45 with diagnosis of nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH) (no cirrhosis), and PCOS, ALT value > 38.

Drug(s): Saroglitizar Magnesium

Interested in this study? Please contact the clinical liver research team: iuliverr@iu.edu